- Report
- August 2026
- 171 Pages
Global
From €5245EUR$5,850USD£4,482GBP
- Report
- August 2026
- 271 Pages
Global
From €5245EUR$5,850USD£4,482GBP
- Report
- August 2026
- 289 Pages
Global
From €5245EUR$5,850USD£4,482GBP
- Report
- November 2025
- 200 Pages
Global
From €7128EUR$7,950USD£6,091GBP
- Report
- July 2026
- 180 Pages
Global
From €4259EUR$4,750USD£3,639GBP
- Report
- July 2026
- 108 Pages
Global
From €4259EUR$4,750USD£3,639GBP
- Report
- June 2026
- 150 Pages
Global
From €4259EUR$4,750USD£3,639GBP
- Report
- July 2026
- 160 Pages
Global
From €3721EUR$4,150USD£3,179GBP
- Report
- July 2026
- 160 Pages
Global
From €3721EUR$4,150USD£3,179GBP
- Report
- January 2026
- 159 Pages
Global
From €4349EUR$4,850USD£3,716GBP
- Report
- September 2025
- 150 Pages
Global
From €4349EUR$4,850USD£3,716GBP
- Report
- December 2025
- 150 Pages
Global
From €4349EUR$4,850USD£3,716GBP
- Report
- November 2025
- 150 Pages
Global
From €4349EUR$4,850USD£3,716GBP
- Report
- September 2025
- 150 Pages
Global
From €4349EUR$4,850USD£3,716GBP
- Report
- December 2021
- 206 Pages
Global
From €4931EUR$5,500USD£4,214GBP
- Report
- February 2025
- 217 Pages
Global
From €3631EUR$4,050USD£3,103GBP
- Report
- March 2025
- 241 Pages
Global
From €4035EUR$4,500USD£3,447GBP
- Report
- March 2025
- 140 Pages
Global
From €4393EUR$4,900USD£3,754GBP
- Report
- January 2024
- 62 Pages
Europe
From €2645EUR$2,950USD£2,260GBP
- Report
- May 2024
- 138 Pages
Global
From €2689EUR$2,999USD£2,298GBP
€3586EUR$3,999USD£3,064GBP

The Stem Cell Transplant market is a subset of the larger stem cell industry. It involves the use of stem cells to treat a variety of diseases and conditions, including cancer, blood disorders, and genetic diseases. Stem cell transplants are used to replace damaged or diseased cells with healthy ones, and can be used to treat a variety of conditions.
The stem cell transplant market is a rapidly growing field, with new treatments and technologies being developed and tested. Companies in the market are focused on developing and commercializing stem cell therapies, as well as providing services related to stem cell transplantation. These companies include Celgene, Novartis, and Osiris Therapeutics. Additionally, there are a number of smaller companies that are focused on developing and commercializing stem cell therapies, such as Athersys, Inc., and Pluristem Therapeutics. Show Less Read more